Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure...
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
About this item
Full title
Author / Creator
Publisher
England: Radcliffe Cardiology
Journal title
Language
English
Formats
Publication information
Publisher
England: Radcliffe Cardiology
Subjects
More information
Scope and Contents
Contents
Sacubitril with valsartan (sacubitril/valsartan) is a relatively novel compound that has become a milestone in the treatment of patients with chronic heart failure (HF) with reduced ejection fraction (HFrEF) in the last decade. Contemporary data suggest that sacubitril/valsartan is associated with improved outcomes compared with angiotensin-convert...
Alternative Titles
Full title
Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f312d9e2247a4d8ab1a5ab02466600bc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f312d9e2247a4d8ab1a5ab02466600bc
Other Identifiers
ISSN
2057-7540
E-ISSN
2057-7559
DOI
10.15420/cfr.2020.25
